These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11779501)

  • 1. Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.
    Irminger-Finger I; Leung WC; Li J; Dubois-Dauphin M; Harb J; Feki A; Jefford CE; Soriano JV; Jaconi M; Montesano R; Krause KH
    Mol Cell; 2001 Dec; 8(6):1255-66. PubMed ID: 11779501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.
    McCarthy EE; Celebi JT; Baer R; Ludwig T
    Mol Cell Biol; 2003 Jul; 23(14):5056-63. PubMed ID: 12832489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase.
    Feki A; Jefford CE; Berardi P; Wu JY; Cartier L; Krause KH; Irminger-Finger I
    Oncogene; 2005 May; 24(23):3726-36. PubMed ID: 15782130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M; Schuechner S; Au WW; Henderson BR
    Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
    Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
    Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.
    Kleiman FE; Manley JL
    Cell; 2001 Mar; 104(5):743-53. PubMed ID: 11257228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies.
    Gautier F; Irminger-Finger I; Grégoire M; Meflah K; Harb J
    Cancer Res; 2000 Dec; 60(24):6895-900. PubMed ID: 11156388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BARD1 expression during spermatogenesis is associated with apoptosis and hormonally regulated.
    Feki A; Jefford CE; Durand P; Harb J; Lucas H; Krause KH; Irminger-Finger I
    Biol Reprod; 2004 Nov; 71(5):1614-24. PubMed ID: 15240424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
    Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
    Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.
    Shakya R; Szabolcs M; McCarthy E; Ospina E; Basso K; Nandula S; Murty V; Baer R; Ludwig T
    Proc Natl Acad Sci U S A; 2008 May; 105(19):7040-5. PubMed ID: 18443292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
    Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
    Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
    J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity.
    Jefford CE; Feki A; Harb J; Krause KH; Irminger-Finger I
    Oncogene; 2004 Apr; 23(20):3509-20. PubMed ID: 15077185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
    Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
    J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1-independent ubiquitination of FANCD2.
    Vandenberg CJ; Gergely F; Ong CY; Pace P; Mallery DL; Hiom K; Patel KJ
    Mol Cell; 2003 Jul; 12(1):247-54. PubMed ID: 12887909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
    Baer R; Ludwig T
    Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA Processing Factor CstF-50 and Ubiquitin Escort Factor p97 Are BRCA1/BARD1 Cofactors Involved in Chromatin Remodeling during the DNA Damage Response.
    Fonseca D; Baquero J; Murphy MR; Aruggoda G; Varriano S; Sapienza C; Mashadova O; Rahman S; Kleiman FE
    Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29180510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
    Brodie KM; Henderson BR
    Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1-dependent and independent functions of BARD1.
    Irminger-Finger I; Leung WC
    Int J Biochem Cell Biol; 2002 Jun; 34(6):582-7. PubMed ID: 11943588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.
    Kleiman FE; Wu-Baer F; Fonseca D; Kaneko S; Baer R; Manley JL
    Genes Dev; 2005 May; 19(10):1227-37. PubMed ID: 15905410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.